NEJM Voices: "Antibiotic Treatment of S. aureus Bacteremia Gets Some Clarity — at Last"
By Paul Sax, M.D.
"For years, clinicians have argued about the optimal antibiotic management of Staphylococcus aureus bacteremia. It’s an important issue, since this condition causes approximately 20,000 deaths a year in the United States alone, with an estimated mortality of 15% to 30%. It is also one of the most common reasons for consultation to ID specialists like me, so we know it well and fear its complications. Now, at long last, the newly published SNAP studies bring welcome clarity."
Click to read the full article.
The study results from the antibiotic backbone domain have now been published in scientific journals!
The SNAP trial includes all age groups because people of all ages.
A summary of how Staphylococcus aureus and penicillin have been instrumental in both the success and failure of one another since they met. Carly Botheras (PhD Candidate, Geelong Centre for Emerging Infectious Diseases, Barwon Health)
